Treatment with praziquantel in a patient with schistosomiasis and chronic renal failure

The pharmacokinetics of praziquantel in a uraemic patient, infected with Schistosoma haematobium, undergoing haemodialysis, was studied by repeated analyses of serum, urine and dialysis fluid. The results indicate the possibility of treating advanced cases of infection with S. haematobium with the normally recommended doses.